Essilor, which sold its former contact lens business to Ocular Sciences, has denied a report that it is interested in acquiring CIBA Vision. With the strong development of Novartis' pharmaceutical business, the world's second-largest contact lens company is becoming less of a core activity for the Swiss-based conglomerate, and in ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.